← Back to patent-cliff list
Pilavapadin
Tier C — Watch / tradePilavapadin
Lexicon Pharmaceuticals Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：AAK1
Indications (approved)：Diabetic neuropathy, Postherpetic neuralgia, Diabetes, 糖尿病周围神经病变
Regional status
US
Phase II
2020-09-03
EU
Phase II
2020-12-10
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Pilavapadin?
Approved indications include: Diabetic neuropathy, Postherpetic neuralgia, Diabetes, 糖尿病周围神经病变.
When does the Pilavapadin patent expire?
No public expiry year is available for Pilavapadin yet; this page updates once verified.
How do I get a quote for Pilavapadin intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-06